Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.

Clinical trial NCT01193335 · COMPLETED

Trial details

NCT number: NCT01193335
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

13-valent Pneumococcal Vaccine Premature Birth Immunization Safety

Start date: 2010-10-01
Primary completion: 2014-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.